Skip to main content

Literature Highlights

Buy Article:

$34.78 + tax (Refund Policy)

Literature Highlights is a digest of notable papers recently published in the leading respiratory journals, allowing our readers to stay up-to-date with research advances. Coverage includes the latest Global Asthma Report; clinical trials of a new BCG vaccine; biomarkers for TB infection vs. active TB; different linezolid doses and durations in a shorter regimen for drug-resistant TB; use of multiplex PCR to reduce inappropriate antibiotic therapy; social contact patterns for airborne pathogens; and natural killer cells in patients with different states of TB infection.

Document Type: Editorial

Affiliations: 1: International Union Against Tuberculosis and Lung Disease, Paris, France 2: Blizard Institute, Queen Mary University, London, UK 3: Novosibirsk, Russian Federation 4: Monash University, Melbourne, VIC, Australia

Publication date: December 1, 2022

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content